Polish Guidelines for Conducting Pharmacoeconomic Evaluations (project)Orlewska E,Mierzejewski P. Polish guidelines for conducting pharmacoeconomic evaluations (project). Farmakoekonomika 2000, Suplement 1: 12-20.Polish guidelines for conducting pharmacoeconomic evaluations by Ewa Orlewska MD, PhD and Piotr Mierzejewski MD provide standards for carrying out and reporting of pharmacoeconomic studies for the purposes of reimbursement submissions in Poland. They focused on objective, use, responsibility for conducting the study, target audience, methodology (population under evaluation, comparator, time horizon, perspective, evaluation technique, identification and measurement of costs and outcomes, data sources, use of dta from other countries, modeling, discounting, presentation of results, sensitivity analysis, financial implications) and ethical code of practice. download Other publications:Orlewska E, Mierzejewski P. Project of Polish guidelines for conducting pharmacoeconomic evaluation in comparison to international health economic guidelines. Eur J of Health Economics 2003, 4(4):296-303 linkPolish Guidelines for Conducting Financial Analysis (project)Orlewska E, Mierzejewski P. Polish Guidelines for Conducting Financial Analysis (project). Farmakoekonomika 2002 Suplement 1: 6-8.Polish guidelines for conducting financial analysis by Ewa Orlewska MD, PhD and Piotr Mierzejewski MD are composed of two sections. The first presents the objective, the use of financial analysis (Budget Impact Analysis, BIA), the responsibility for the preparation, and the target audience. The second section presents important methodological aspects that researchers should keep in mind when carrying out BIA. It includes recommendations on perspective, time horizon, reliability of data sources, reporting of results, rates of adoption of new therapies, probability of re-deploying resources. download Other publications:Orlewska E, Mierzejewski P. Proposal of Polish Guidelines for Conducting Financial Analysis and their comparison to existing guidance on Budget Impact in Other countries. Value in Health 2004 7(1): 1-10.linkPolish guidelines for cost calculation in the economic evaluation of healthcare programs (project)Orlewska E, Mierzejewski P. Polish guidelines for cost calculation in the economic evaluation of healthcare programs (project). Farmakoekonomika 2003, 1: 3-6.Polish guidelines for cost calculation in the economic evaluation of healthcare programs by Ewa Orlewska MD, PhD and Piotr Mierzejewski MD contain basic principles of standardization of costing, description of stages in costing procedure, description of presentation of results, standard costs and standard values (values that can be used within unit cost calculation). They form an integral part of the guidelines for conducting pharmacoeconomic and financial analysis. download |
|||||